Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Precision Biosciences, Inc.
organization4 mentionslast seen Nov 9, 2026
Clinical stage biotechnology company on whose board Geno J. Germano has served since March 2020.
Relationships 10
- Precision Biosciences, Inc.employsNaresh Tanna99% confidence3 sources
- Precision Biosciences, Inc.developsPBGENE-DMD99% confidence3 sources
- Precision Biosciences, Inc.developsPBGENE-HBV99% confidence3 sources
- Precision Biosciences, Inc.developsARCUS99% confidence2 sources
- Precision Biosciences, Inc.employsCassie Gorsuch97% confidence1 source
- Precision Biosciences, Inc.employsMichael Amoroso97% confidence1 source
- Precision Biosciences, Inc.funded byPrecision BioSciences November 2026 Underwritten Offering95% confidence1 source
- First Light Asset Managementinvests inPrecision Biosciences, Inc.80% confidence1 source
- MPM BioImpactinvests inPrecision Biosciences, Inc.80% confidence1 source
- Bleichroeder LPinvests inPrecision Biosciences, Inc.80% confidence1 source
Relationship
Precision Biosciences, Inc.developsPBGENE-HBV
99% confidence3 supporting mentions
Either name opens that entity’s relationships.
Sources 3
- filingSEC EDGARNov 9, 2026PRECISION BIOSCIENCES INC 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
the Company projects it is sufficiently capitalized to fund both PBGENE-HBV and PBGENE-DMD clinical programs
- filingSEC EDGARNov 6, 2026PRECISION BIOSCIENCES INC 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Precision intends to use the net proceeds of the offering to fund the continued research and development of PBGENE-HBV
- filingSEC EDGARNov 5, 2026PRECISION BIOSCIENCES INC 8-K: Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS ® genome editing platform